Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

Guadalupe Antelo, Abhishek A. Mangaonkar, Giacomo Coltro, Ajinkya Buradkar, Terra L. Lasho, Christy Finke, Ryan Carr, Moritz Binder, Naseema Gangat, Aref Al-Kali, Michelle A. Elliott, Rebecca L. King, Matthew Howard, Megan E. Melody, William Hogan, Mark R. Litzow, Ayalew Tefferi, Martin E. Fernandez-Zapico, Rami Komrokji, Mrinal M. Patnaik

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e104-e108
JournalBritish journal of haematology
Volume189
Issue number3
DOIs
StatePublished - May 1 2020

Keywords

  • ESA
  • MDS-RS
  • MDS/MPN-RS-T
  • erythropoiesis stimulating agents
  • myeloid leukaemia
  • sideroblastic anaemia

ASJC Scopus subject areas

  • Hematology

Cite this